Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: Results from a tertiary care center

Peyrin-Biroulet, 2011, Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts, Inflamm Bowel Dis, 17, 471, 10.1002/ibd.21417 Andrews, 1989, Mortality in Crohn's disease — a clinical analysis, Q J Med, 71, 399 Grainge, 2010, Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study, Lancet, 375, 657, 10.1016/S0140-6736(09)61963-2 Bernstein, 2001, The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study, Thromb Haemost, 85, 430, 10.1055/s-0037-1615600 Kappelman, 2011, Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study, Gut, 60, 937, 10.1136/gut.2010.228585 Nguyen, 2008, Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients, Am J Gastroenterol, 103, 2272, 10.1111/j.1572-0241.2008.02052.x Murthy, 2011, Venous thromboembolism in inflammatory bowel disease: an epidemiological review, Am J Gastroenterol, 106, 713, 10.1038/ajg.2011.53 Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103 Leizorovicz, 2004, Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients, Circulation, 110, 874, 10.1161/01.CIR.0000138928.83266.24 Kornbluth, 2010, Gastroenterology PPCotACo. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee, Am J Gastroenterol, 105, 501, 10.1038/ajg.2009.727 Kahn, 2012, Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e195S, 10.1378/chest.11-2296 Travis, 2008, European evidence-based consensus on the management of ulcerative colitis: current management, J Crohns Colitis, 2, 24, 10.1016/j.crohns.2007.11.002 Mowat, 2011, Guidelines for the management of inflammatory bowel disease in adults, Gut, 60, 571, 10.1136/gut.2010.224154 Cohen, 2008, Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study, Lancet, 371, 387, 10.1016/S0140-6736(08)60202-0 Yu, 2007, Hospitals' compliance with prophylaxis guidelines for venous thromboembolism, Am J Health Syst Pharm, 64, 69, 10.2146/ajhp060115 Amin, 2007, Thromboprophylaxis rates in US medical centers: success or failure?, J Thromb Haemost, 5, 1610, 10.1111/j.1538-7836.2007.02650.x Tapson, 2007, Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism, Chest, 132, 936, 10.1378/chest.06-2993 Amin, 2010, Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start), J Thromb Thrombolysis, 29, 326, 10.1007/s11239-009-0361-z Amin, 2009, Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients, J Hosp Med, 4, E15, 10.1002/jhm.526 Tinsley, 2013, A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States, J Clin Gastroenterol, 47, e1, 10.1097/MCG.0b013e31824c0dea Sam, 2013, Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease, Dig Dis Sci, 58, 46, 10.1007/s10620-012-2435-6 Kakkar, 2010, Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients, Ann Surg, 251, 330, 10.1097/SLA.0b013e3181c0e58f Folwaczny, 1999, Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease, Am J Gastroenterol, 94, 1551, 10.1111/j.1572-0241.1999.01143.x Evans, 1997, Treatment of corticosteroid-resistant ulcerative colitis with heparin — a report of 16 cases, Aliment Pharmacol Ther, 11, 1037, 10.1046/j.1365-2036.1997.00252.x